ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

A Gennari; F André; C H Barrios; J Cortés; E de Azambuja; A DeMichele; R Dent; D Fenlon; J Gligorov; S A Hurvitz; S-A Im; D Krug; W G Kunz; S Loi; F Penault-Llorca; J Ricke; M Robson; H S Rugo; C Saura; P Schmid; C F Singer; T Spanic; S M Tolaney; N C Turner; G Curigliano; S Loibl; S Paluch-Shimon; N Harbeck; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

doi:10.1016/j.annonc.2021.09.019

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Ann Oncol. 2021 Dec;32(12):1475-1495. doi: 10.1016/j.annonc.2021.09.019. Epub 2021 Oct 19.

Authors

A Gennari¹, F André², C H Barrios³, J Cortés⁴, E de Azambuja⁵, A DeMichele⁶, R Dent⁷, D Fenlon⁸, J Gligorov⁹, S A Hurvitz¹⁰, S-A Im¹¹, D Krug¹², W G Kunz¹³, S Loi¹⁴, F Penault-Llorca¹⁵, J Ricke¹⁶, M Robson¹⁷, H S Rugo¹⁸, C Saura¹⁹, P Schmid²⁰, C F Singer²¹, T Spanic²², S M Tolaney²³, N C Turner²⁴, G Curigliano²⁵, S Loibl²⁶, S Paluch-Shimon²⁷, N Harbeck²⁸; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Affiliations

¹ Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
² Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif, France.
³ Oncology Research Center, Grupo Oncoclínicas, Porto Alegre, Brazil.
⁴ International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain; Scientific Department, Medica Scientia Innovation Research, Valencia, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain.
⁵ Medical Oncology Department, Institute Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
⁶ Hematology/Oncology Department, Hospital of the University of Pennsylvania, Philadelphia, USA.
⁷ Department of Medical Oncology, National Cancer Centre Singapore, Singapore.
⁸ College of Human and Health Sciences, Swansea University-Singleton Park Campus, Swansea, UK.
⁹ Départment d' Oncologie Médicale, Institut Universitaire de Cancérologie AP-HP, Sorbonne Université, Hôpital Tenon, Paris, France.
¹⁰ Department of Medicine/Division of Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, USA; Jonsson Comprehensive Cancer Center, Los Angeles, USA.
¹¹ Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
¹² Department of Radiation Oncology, University Hospital Schleswig-Holstein-Campus Kiel, Kiely, Germany.
¹³ Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
¹⁴ Peter MacCallum Cancer Centre, Melbourne, Australia.
¹⁵ Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR INSERM-UCA, Clermont Ferrand, France.
¹⁶ Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif, France; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
¹⁷ Medicine Department, Memorial Sloan Kettering Cancer Center, New York, USA.
¹⁸ Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
¹⁹ Breast Cancer Program, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
²⁰ Centre of Experimental Cancer Medicine, Cancer Research UK Barts Centre, Barts and The London School of Medicine and Dentistry, London, UK.
²¹ Center for Breast Health and Department of Obstetrics & Gynecology, Medical University of Vienna, Vienna, Austria.
²² Europa Donna Slovenia, Slovenia, USA.
²³ Dana-Farber Cancer Institute, Boston, USA.
²⁴ The Royal Marsden Hospital NHS Foundation Trust, London, UK.
²⁵ Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS and University of Milano, Milan, Italy.
²⁶ GBG Forschungs GmbH, Neu-Isenburg, Germany.
²⁷ Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel.
²⁸ Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.

PMID: 34678411
DOI: 10.1016/j.annonc.2021.09.019

No abstract available

Keywords: ESCAT; ESMO Clinical Practice Guideline; ESMO-MCBS; diagnosis; metastatic breast cancer; treatment.

Publication types

Practice Guideline
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Breast Neoplasms* / diagnosis
Breast Neoplasms* / therapy
Female
Humans
Medical Oncology